symptomatic Botulism caused by Clostridium botulinum serotype C

DBCOND0093877Ancillary infectious topics Bacterial Infections

symptomatic Botulism caused by Clostridium botulinum serotype C is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under: Ancillary infectious topics
Bacterial Infections
Chemically-Induced Disorders
Digestive System Diseases
Gram Positive Bacteria
Nervous System Diseases
Public Health
Signs and Symptoms
Indicated drugs: Equine Botulinum Neurotoxin C Immune FAB2

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

Which approved drugs for symptomatic Botulism caused by Clostridium botulinum serotype C share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account